- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05008523
Opioids and Police Safety Study (OPS)
Evaluation of an Experimental Educational Module on Opioid-related Occupational Safety to Minimize Barriers toOverdose Response Among Police Officers
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10010
- New York University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Active duty Police Officer
Exclusion Criteria:
- Desk only- not active duty
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Opioids and Police Safety Occupational Risk Reduction Training
Provides occupational risk reduction training for police in 49 slides including 8 filmed videos (police officers, MDs, SSP staff, a person in recovery).
The training is delivered online with secure access only for enrolled study participants.
|
Potential participants are provided with a flyer with directions to enroll online.
Groups are randomized by zip code (all participants with the same zip code receive the same training to avoid contamination by precinct) Both the experimental and control groups first take the online GetNaloxoneNow.org
First Responder training; then the experimental group takes the online OPS training and the control group takes the online COVID training.
Both groups take a pre-survey prior to both trainings and a post-survey after they complete both trainings.
Both groups also receive (via email) a resource list with information that was provided in their respective trainings plus additional resources re: occupational risk reduction appropriate to each training.
Every quarter for one year, participants are emailed a reminder to get back online to take the survey again.
Other Names:
|
|
Active Comparator: COVID Occupational Risk Reduction Training
The COVID-19 and Police Safety training (Control only) includes 22 slides, also narrated by a professional voice narrator.
|
Potential participants are provided with a flyer with directions to enroll online.
Groups are randomized by zip code (all participants with the same zip code receive the same training to avoid contamination by precinct) Both the experimental and control groups first take the online GetNaloxoneNow.org
First Responder training; then the experimental group takes the online OPS training and the control group takes the online COVID training.
Both groups take a pre-survey prior to both trainings and a post-survey after they complete both trainings.
Both groups also receive (via email) a resource list with information that was provided in their respective trainings plus additional resources re: occupational risk reduction appropriate to each training.
Every quarter for one year, participants are emailed a reminder to get back online to take the survey again.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Naloxone Behavioral Outcomes in Policing Procedure
Time Frame: Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Number of days during the past 30 days in which participants had naloxone available and carried naloxone while at work.
|
Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Change in Naloxone Behavioral Outcomes in Policing Procedure
Time Frame: Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Number of days during the past 30 days in which participants had naloxone available and carried naloxone outside of work hours.
|
Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Change in Naloxone Behavioral Outcomes in Policing Procedure
Time Frame: Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Number of days during the past 30 days in which participants responded to an OD event, attempted to intervene, and/or administered naloxone.
|
Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Change in Referral Behavioral Outcomes in Policing Procedure
Time Frame: Time frame: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Number of referrals to evidence-based or other drug treatment or social services made during the past 30 days.
|
Time frame: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Change in Confiscation Behavioral Outcomes in Policing Procedure
Time Frame: Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Number of episodes involving syringe confiscation in the past 30 days (with/without proper technique).
|
Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Change in Confiscation Behavioral Outcomes in Policing Procedure
Time Frame: Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Number of episodes in the past 30 days involving drug confiscation (with/without proper technique).
|
Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in participant knowledge about needle stick injury and treatment
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Which of the following diseases is MOST likely to be transmitted by a needle stick injury?
|
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Change in participant knowledge about needle stick injury and treatment
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
The risk of getting a bloodborne infection as a result of a needle stick injury is high (check only one response).
|
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Change in participant knowledge about needle stick injury and treatment
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
To avoid being stuck with a needle, police officers should (select ALL that apply)
|
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Change in participant knowledge about needle stick injury and treatment
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
The evidentiary value of syringes and any drug residue therein is (fill in the blank by checking only one response). 5) Possession of syringes is (fill in the blank by checking only one response). 6) Confiscating syringes from people who inject drugs... (check all that apply): 7) Testing and precautionary treatment of any NSI is important, because... (fill in the blank by checking only one response). |
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Change in participant knowledge about needle stick injury and treatment
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Possession of syringes is (fill in the blank by checking only one response).
6) Confiscating syringes from people who inject drugs... (check all that apply): 7) Testing and precautionary treatment of any NSI is important, because... (fill in the blank by checking only one response).
|
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Change in participant knowledge about needle stick injury and treatment
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Confiscating syringes from people who inject drugs... (check all that apply): 7) Testing and precautionary treatment of any NSI is important, because... (fill in the blank by checking only one response). |
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Change in participant knowledge about needle stick injury and treatment
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Testing and precautionary treatment of any NSI is important, because... (fill in the blank by checking only one response).
|
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Degree of participant familiarity with proper technique for dealing with contaminated injection equipment
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Please indicate your agreement with the following statements relating to needle stick prevention and response (1 = strongly agree, 2 = agree, 3 = neither agree nor disagree, 4 = disagree, 5 = strongly disagree):
|
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Degree of participant awareness of post-exposure prophylaxis (PEP) and its uses
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
(1 = strongly agree, 2 = agree, 3 = neither agree nor disagree, 4 = disagree, 5 = strongly disagree):
|
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Degree of participant awareness of risk of fentanyl exposure and proper technique for dealing with synthetic opioids
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Response options: (1 = all the time, 2 = most of the time, 3 = sometimes, 4 = rarely, 5 = never):
|
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Degree of participant familiarity with fentanyl-class substances
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Degree of participant familiarity with best-practices related to policing PWUO and PWID who may be carrying heroin contaminated with fentanyl-class substances
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Opioid-Related OD knowledge
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
The items related to a participant's ability to recognize and respond to an opioid-related overdose, with or without naloxone, were adapted from the Opioid Overdose Knowledge Scale (OOKS).
|
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Hypothesized Mediators of Intervention Efficacy: Stigma
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Response options: 1 = strongly agree, 2 = agree, 3 = neither agree nor disagree, 4 = disagree, 5 = strongly disagree Providing naloxone to people with addiction enables more risky drug use Distributing naloxone widely in the community is a good way to reduce overdose fatalities Rapidly giving a lot of naloxone (blasting) when reversing an overdose is a good way to teach someone a lesson It is important to prevent overdose risk directly following a period of incarceration I worry about my safety when I encounter people with addiction People with addiction make communities less safe People with addiction can make positive health choices to protect themselves or others When people with addiction are placed in secure /mandated treatment facilities, communities are better off A lot of people with addiction are outsiders coming into communities to peddle drugs
|
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Potential Moderators: Demographic Variables
Time Frame: Baseline
|
|
Baseline
|
|
Potential Moderators: Perceived Attitudes/Expectations
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Response options: 1 = strongly agree, 2 = agree, 3 = neither agree nor disagree, 4 = disagree, 5 = strongly disagree
|
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Prior instances of witnessing an opioid-related overdose
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
The following questions relate to your experiences with opioid overdose. For each item, please choose what best describes your response to each statement (select ONLY one for each item).
|
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Prior instances of working with syringes
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
The following questions cover your experiences with syringes in the line of duty. Select the one best response for each item:
|
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Prior instances responding to an overdose
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Now please tell us just about the following events which you may have experienced when responding to an overdose in the past 3 months.
|
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
|
Experiences with other programs
Time Frame: [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
This next set of questions relate to your experiences with other programs in addressing the overdose crisis in your community:
|
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Chemically-Induced Disorders
- Substance-Related Disorders
- Narcotic-Related Disorders
- Opioid-Related Disorders
- Drug Overdose
- Opiate Overdose
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Narcotics
- Analgesics, Opioid
Other Study ID Numbers
- IRB-FY2019-3315
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Opioid Overdose
-
Isfahan University of Medical SciencesCompletedMorphinan Opioid OverdoseIran, Islamic Republic of
-
Edward HospitalCompletedOpioid Use Disorder | Opioid DependenceUnited States
-
University of PittsburghNational Institute on Drug Abuse (NIDA)RecruitingOpioid Use Disorder | Opioid Use | Opioid Overdose | OpioidsUnited States
-
Unity Health TorontoUniversity of Toronto; Toronto Public Health; Ontario College of Art and Design...WithdrawnOpioid-Related Disorders | Opioid Use | Education | Opioid Withdrawal | Opioid Overdose | ResusitationCanada
-
BC Centre on Substance UseIndivior Inc.RecruitingOpioid Overdose | Opioid-Use DisorderCanada
-
University of PennsylvaniaCompletedSubstance Use Disorders | Opioid-use Disorder | Opioid OverdoseUnited States
-
University of CincinnatiCompletedOpioid Dependence | Substance Abuse | Overdose | Drug Overdose | Drug Abuse | Drug Addiction | Opioid-related Disorders | Opioid Use, UnspecifiedUnited States
-
VA Office of Research and DevelopmentCompletedPain | Drug Overdose | Opioid Use DisordersUnited States
-
Nassima Ait-Daoud TiouririneUnknown
Clinical Trials on Opioids and Police Safety Occupational Risk Reduction Training (OPS)
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)CompletedHIV Infections | Chlamydia | GonorrheaChina
-
UConn HealthNational Institute on Minority Health and Health Disparities (NIMHD)CompletedContingency Management | HIV | HIV Testing | WomenUnited States
-
Emory UniversityCompletedHIVUnited States, South Africa